"Anti-Asthmatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are used to treat asthma.
| Descriptor ID |
D018927
|
| MeSH Number(s) |
D27.505.954.796.050
|
| Concept/Terms |
Anti-Asthmatic Agents- Anti-Asthmatic Agents
- Agents, Anti-Asthmatic
- Anti Asthmatic Agents
- Anti-Asthmatics
- Anti Asthmatics
- Antiasthmatic Drugs
- Drugs, Antiasthmatic
- Antiasthmatics
- Anti-Asthmatic Drugs
- Anti Asthmatic Drugs
- Drugs, Anti-Asthmatic
- Antiasthmatic Agents
- Agents, Antiasthmatic
|
Below are MeSH descriptors whose meaning is more general than "Anti-Asthmatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Asthmatic Agents".
This graph shows the total number of publications written about "Anti-Asthmatic Agents" by people in this website by year, and whether "Anti-Asthmatic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 2 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 4 | 6 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 2 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 5 | 0 | 5 |
| 2016 | 2 | 2 | 4 |
| 2017 | 5 | 1 | 6 |
| 2018 | 7 | 1 | 8 |
| 2019 | 6 | 1 | 7 |
| 2020 | 7 | 1 | 8 |
| 2021 | 4 | 1 | 5 |
| 2022 | 7 | 0 | 7 |
| 2023 | 6 | 1 | 7 |
| 2024 | 5 | 1 | 6 |
| 2025 | 9 | 2 | 11 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Asthmatic Agents" by people in Profiles.
-
Association of Inhaled Corticosteroid and Long-Acting Beta Agonist Combination Versus Inhaled Corticosteroid Only Inhalers on Adherence and Asthma Outcomes. Pediatr Pulmonol. 2026 May; 61(5):e71673.
-
A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Asthma. Ann Intern Med. 2026 Apr; 179(4):564-573.
-
Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study. Int J Chron Obstruct Pulmon Dis. 2026; 21:562498.
-
Persistent airway obstruction in severe eosinophilic asthma: targeting interleukin-5 and eosinophils. Eur Respir Rev. 2025 Oct; 34(178).
-
Disparities in asthma control and treatment: A spotlight on Mexican American children. J Allergy Clin Immunol. 2026 May; 157(5):1034-1042.
-
Association of Stepping Up to High-Dose Inhaled Corticosteroids and Risk of Future Asthma Exacerbations: Data From the United States. J Allergy Clin Immunol Pract. 2026 Jan; 14(1):122-135.e10.
-
Biologic Management in Severe Asthma for Adults: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2026 Feb; 169(2):336-348.
-
Adherence to inhaled corticosteroid medications after an asthma exacerbation and the risk of subsequent exacerbations. Ann Allergy Asthma Immunol. 2026 Feb; 136(2):160-167.e4.
-
Biologics for severe asthma: deciphering what is best for the patient. Expert Rev Clin Immunol. 2025 Aug; 21(8):1035-1054.
-
Burden of Oral Corticosteroid Use in Severe Asthma: Challenges and Opportunities. Allergy. 2025 Aug; 80(8):2113-2127.